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Effective management of cancer pain is often hampered by patients’ lack of knowledge regarding cancer pain 
management and other barriers related to ethnicity and religious beliefs. This cross sectional study was 
performed to determine the patient-related barriers to effective cancer pain management. One hundred patients 
receiving cancer pain management were studied. Inclusion criteria were: patients over the age of 18 years, able 
to communicate, with known diagnosis of cancer, experiencing persistent pain for the past two weeks. A 
modified version of the Barriers Questionnaire II (BQ-II) was used and a modified Brief Pain Inventory was 
used to assess the pain profile. Barriers such as, patient’s attitude and beliefs, communication skills and fear of 
side effects of pain medication were determined, given a score and the summation was recorded as the total 
patient related barriers score. Overall, 85% of respondents achieved more than 40% pain relief and the 72 of 100 
patients reported low patient related barrier scores of 6 or less. Nevertheless, the main patient related barriers 
were: fear of tolerance to opioids (51%), ethnicity (p=0.003) and religious beliefs (p=0.002) which constituted 
the major components of the patient-related barriers score. Ethnicity and religious beliefs had significant 
influence on patient-related barriers score suggesting the need of further investigation into this area. In order to 
achieve a comprehensive view, other barriers to effective cancer pain management such as those related to the 
health systems and healthcare providers need to be assessed together. 
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Introduction 
 
Cancer pain relief is achieved by the use of a team 
approach, careful monitoring of pain, adjustment of 
treatment strategy and continued assessment of 
treatment effectiveness (1,2,3).  Patients and their 
families are units of care and issues affecting 
caregivers can also affect patients’ care (4,5).  
Adherence to guidelines for cancer pain 
management has shown to improve pain treatment 
efficacy (p<0.02) compared to standard care (6).  
 
Sub-optimal management of cancer pain has been 
reported worldwide (7). Various studies have 
suggested that poor management of cancer pain may 
be attributed to the attitudes of patients and 
healthcare providers, rather than the lack of 
effective pain treatment (8,9,10).  Ward et al. (1993) 
developed a Barriers Questionnaire (BQ) which was 
updated to Barriers Questionnaire II (BQ-II) in 2002 
with an aim to examine patient-related barriers to 
effective cancer pain management (11,12,13,14).  
WHO in 1996 reported that satisfactory cancer pain 
relief could be achieved in 90% of patients using 
pharmacological therapy (15). Unfortunately, 
reports of better cancer pain relief in different 
clinical settings have been found to be lacking.  
 
The present study aimed to determine patient related 
barriers to cancer pain management and to identify 
factors important in a local setting. Factors that were 
assessed included: socio-demographic profile, type 
of cancer diagnosis, pain profile, patients’ 
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knowledge on cancer pain management (CPM), and 
usage of complementary medication. The present 
paper aims to make contribution towards improving 
cancer pain management in South East Asian region 
 
Materials and Methods 
 
This cross-sectional study was conducted during 
29/10/2009-25/4/2010 on cancer patients admitted 
to the Surgery, Oncology, Obstetric & Gynaecology 
wards and Oncology clinics with approval from the 
ethics committee.   
 
A universal sample consisting of 100 cancer patients 
were recruited for this study. The inclusion criteria 
were:- patients over the age of 18 years with known 
diagnosis of cancer, who had persistent pain for the 
past two weeks, being prescribed pain medication 
(oral, topical, parenteral) and able to communicate. 
Exclusion criteria were: patients who have major 
psychiatric disorders and terminally ill cancer 
patients.  
A structured questionnaire was developed which 
incorporated items from the Barriers Questionnaire-
II (BQ-II) (Internal reliability: alpha Cronbach’s 
score of 0.89) by Wards et al. (2002) to act as a tool 
which enabled determination of patient-related 
barriers to cancer pain management (12). Barriers 
such as, patient’s attitude and beliefs, 
communication, fear of side effects, addiction and 
tolerance to pain medication were determined and 
given a score, the summation of which was recorded 
as the patient related barrier (PRB) score which 
consists of 14 items (Figure 3) each given one point 
while the item on side effects of medications (11 
types: 1. Nausea and vomiting; 2. Drowsiness; 3. 
Constipation; 4. Problems with urination; 5. 
Nightmares; 6. Lack of appetite; 7. Difficulty in 
sleeping; 8. Tiredness; 9. Diarrhea; 10. Itchiness; 11. 
Sweating)  given 11 points amount to a maximum of 
24 points. A modified version of the “Brief Pain 
Inventory” (BPI) was used to determine patient’s 
pain profile, usage of analgesics and adverse effects 
from pain (16).  
 
Data was entered and analyzed using the Statistical 
Package for Social Science (SPSS) version 19. The 
relation between ethnicity, religious beliefs, 
education level and PRB scores were tested for 
statistical significance by the ANOVA test. Non 
parametric test was used to analyze the relationship 
between age, gender and PRB scores. All statistical 





A total of 100 subjects consented to participate in 
this study. Subject’s socio-demographic and health 
characteristics were shown in Table 1. It may be 
mentioned that the ethnic population of Malaysia 
comprises of Malays, Chinese and Indians and the 
majority belong to the Islamic religion followed by 
Christians, Buddhists and Hindus. The age 
distribution reflected involvement of the older age 
group, of whom 54% were 60 years or more. The 
malignancies studied included: gastrointestinal 
(26%), gynaecological (23%), breast (10%), head 
and neck (8%), prostate (6%), lung (5%) and other 
cancers (21%). 
 
In terms of age difference, older patients (60 years 
old or more) tend to perceive less control over their 
cancer pain (48.1 %) than younger patients (34.8%), 
as well as more willing to tolerate pain (70.4%) 
compared to younger patients (65.2%), although this 
was not statistically significant. A total of 39.7% 
and 50% of all women preferred to tolerate pain and 
preferred to “save” the medication to be used when 
the pain got worse, respectively. In the case of male 
patients, the corresponding figures were 21.4% and 
33.3% respectively. There was no significant 
correlation of total pain score to patient related 
barriers, including each subcategory: current pain (p 
= 0.804), and worst pain in 24 hours (p = 0.346). 
(Fig. 1). 85% of patients reported satisfactory pain 
relief (at least 40% of pain relief) (Fig. 2). There 
were no significant differences in terms of current 
pain, worst pain, average pain in 1 week and reported 
 
Table 1: Table showing demographic data of respondents 
 
 N =100 
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Figure 3: PRB Scores among respondents 
 
reported satisfactory pain relief with respect to the 
different types of cancers. 
 
The PRB scores amongst the respondents were low 
which ranged between 3 and 6 (51%) whereby the 
maximum possible score is 24 (Fig. 3). Significant 
differences were found in the PBR scores. There 
were significant differences amongst the different 
races with respect to the PRB score. Tukey HSD’s 
post-hoc test revealed significant difference between 
Malay and Chinese (p = 0.003).  Malays had the 
highest PRB score. (6.10 ± 2.77). In terms of 
religion, there was a significant difference between 
groups; Tukey HSD’s post-hoc test revealed 
significant difference between Muslims and 
Buddhists (p = 0.002) with Muslims having the 
highest PRB score (5.80 ± 2.74). Other factors such 
as: gender, age group (60 years and above or lower 
than 60 years), education level and knowledge 
regarding cancer pain management, were not 
significantly related to the PRB scores, in any way.  
 
However, females (5.17 ± 2.61) scored higher than 
males (4.69 ± 3.13) for PRB  (41.01 ± 7.77), while 
subjects who were less than 60 years scored (4.97 ± 
3.17) for PRB while those who were 60 years and 
above scored (4.96 ± 2.54). In terms of patient 
related factors, a comparison of those who agree or 
disagree with these factors and the relation to the 




Patient-related factors found to be important were: 
fear of tolerance to medication, ethnicity and 
religious beliefs. This was in accordance with a 
previous study which found that fear of tolerance 
was one of the major patient-related barrier (17). 
Decreased effectiveness of pain medication can be 
multi-factorial, ranging from a probable increase in 
cancer pain with advanced disease, true 
physiological tolerance and psychological tolerance 
to pain medications.  
 
An earlier study found that 41% of patients were 
adherent (p = 0.005) to medication and this could be 
explained by the fact that patients with higher pain 
relief scores were more adherent with their analgesic 
regimen (18). In agreement with findings in this 
study, other researchers had stated that the patients 
who had better pain relief were more adhered to 
cancer pain management (19).  
 
According to past research, pain assessment in the 
elderly needs extra caution as they may have a short 
attention span and difficulties in comprehending the 
questions, particularly those with cognitive 
impairment and this may confound the findings in 
this study (20). A research study found that older 
patients reported higher pain severity than those of 
60 years or less (21).  We found no difference in 
variations of pain severity between those who were 
60 years and above or below 60 years age groups. 
We found that gender had no influence on all 
components of the (PRB) score. It has been reported 
that overt pain behaviour was more acceptable to 
women than men (22). A past study stated that 
ethnicity can affect a patient’s response to pain and 
this can impact on pain management and may be 
related to the reluctance to use pain medication and 
the believe that pain as a form of punishment from 
God (23).  In this study, Malays had more barriers 
than Chinese (p = 0.003). Studies reported the 
differences in pain reporting and pain treatment 
between different ethnic groups as they would 
probably be influenced by their own different 
cultural views of pain and its management (24). 
However, another research study reported the 
differences in healthcare seeking behaviour of cancer 
Cancer pain management     Choy YC et al. 






















Figure 4: Bar chart showing types of Patient-Related Barriers 
 
Legend:  
Patient related barriers: Agree (PRB score) 
Disagree 
(PRB score) P value 
A: Prolonged usage of pain medication can cause tolerance 3.86 ±2.60 6.12±2.52 <0.05 
B: Pain is a sign of progression of illness and should not be  masked  5.89 ±2.76 4.15±2.67 0.002 
C: Pain medication should be saved for when the pain gets worse 6.69 ±2.51 3.66±2.634 <0.05 
D: Cancer pain cannot be controlled/ relieved  6.26 ±2.37 4.18 ±2.65 0.002 
E: Influence from family and friends in pain management  5.54 ±2.18 4.58 ±3.17 0.076 
F: Rather save pain medication in case the pain gets worse  6.70 ±2.51 3.67±2.34 <0.05 
G: Rather tolerate moderate pain until it worsens before calling the nurse  6.66 ±2.50 4.18 ±2.65 <0.05 
H: Believe that pain medication can lead to addiction easily  7.07±2.48 4.07±2.50 <0.05 
I: Deserves to feel pain as a form of punishment from god  7.79 ±2.12 4.07±2.42 <0.05 
J: Side effects of pain medication is unbearable 7.92 ±2.32 4.52±2.64 <0.05 
K: Tolerates side effects of pain medication  7.92 ±2.03 4.53 ±2.65 <0.05 
L: Believe that complaining about pain may distract the doctor  8.62 ±3.07 4.65 ±2.60 0.008 
M: Pain medication is not helpful 4.80 ±2.78 4.98 ±2.58 0.895 
N: Prefers to bear the pain instead of using pain medication 6.66 ±2.50 4.18 ±2.65 <0.05 
 
cancer patients and found that there was no 
difference in terms of ethnicity (25). In the 
literature, there has been reported that different 
ethnic groups had different pain thresholds as 
indicated by different degrees of unpleasantness 
from thermal pain felt among African-Americans 
and Caucasians (26).  
 
Education level had no significant effect on PRB.  A 
higher education level would enable patients easily 
understand these education programmes. 
Admittedly, we were not able to carry out any 
patient education program to assess this. A research 
study reported the effectiveness of a pain 
educational program to overcome patient-related 
barriers. They reported an improvement of 
adherence, from 22 to 72% (p <0.05) of patients 
who had completed a pain education programme. 
On the contrary, there was no change in the control 
group which accounted to 16% (27). Results of this 
study did not show any association between 
knowledge of CPM and PRB scores. However, there 
were various misbelieve regarding cancer pain 
which result in barriers towards effective CPM. This 
reflects their poor understanding on CPM.  
 
A previous study found that patients who had many 
mistaken beliefs about cancer pain  reported more 
pain at time of interview, pain scores in the upper 
region of the VAS pain scale, and also persistent 
severe pain in the preceding day (28). It has been 
reported that patients with higher pain intensity 
showed higher adherence to cancer pain 
management as they tend to have lower beliefs (19). 
Valeberg BT et al, found that 3.0% of the variance 
(p = 0.018) could be explained by the group of 
patients who had greater average pain severity. 
These patients were more adherent with their 
prescribed analgesic medications (18).  
 
This study was limited by the exclusion of patients 
with advanced cancer. Research studies in Korea 
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reported that cancer pain was relatively poorly 
managed in patients with advanced malignancies 
(29). Those Korean studies were conducted on 655 
cancer patients from eight university hospitals (29).  
Many cancer patients with significant metastases in 
advanced disease were not able to participate in this 
study, making it difficult to achieve a truly 
representative sample. An earlier study reported that 
two thirds of the patients with metastatic cancer had 
pain or had consumed analgesic drugs daily during 
the week preceding the study, and one third of them 
had pain severe enough to impair their ability to 
function (30). Okuyama T el al., by logistic 
regression (p= 0.009, odds ratio = 0.18) found 
patients with well controlled cancer more compliant 
to treatment than those with advanced cancer (31). 
 
Earlier studies had reported the usage of 
complementary medicine (CM) to be high (63.9%). 
(63.9%) amongst patients who have chronic illness 
(32). An earlier research study also reported that the 
most common reason patients used CM (69%) was a 
desire to feel hopeful (33). Thus, there is ample 
reason to belief that the usage of CM is a result of 
high PRB, whereby patient’s negative thoughts 
towards conventional CPM could be a factor 
towards the usage of CM. However, the results 
showed that although there was a difference 
between PRB scores of CM users and non users, the 
results were not significant. The present study 
showed that majority of patients had adequate 





In conclusion, important patient related barriers to 
cancer pain management are as follows: “fear of 
tolerance to pain medication”, “belief that pain 
should not be masked as it is a sign of progression 
of the illness”, “belief that pain should be saved for 
when the pain gets worse”, “belief that cancer pain 
cannot be controlled/relieved”, “belief that one 
rather tolerate moderate pain until it worsens before 
calling the nurse”, “belief that to feel pain as a form 
of punishment from god”, “belief that side effect of 
pain medication is unbearable” and “belief that 
complaining about pain may distract the doctor from 
treatment of underlying disease”. Ethnicity and 
religious beliefs had significant influence on PRB 
score suggesting the need for further investigation 
into this area. CPM should be tailored to each 
patient’s needs and patients should be educated on 
CPM through proper education programs. In order 
to achieve a comprehensive view other barriers to 
effective CPM such as those related to the health 
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